New Pegloticase and Treatment Failure Gout Data to be Featured in Six Abstracts At American College of Rheumatology 72nd Annual Scientific Meeting
September 22, 2008 08:00 ET
|
Savient Pharmaceuticals, Inc.
EAST BRUNSWICK, N.J., Sept. 22, 2008 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) announced today that four scientific abstracts on pegloticase and two scientific abstracts based...
Savient Pharmaceuticals to Present At Jefferies 2nd Annual Healthcare Conference On June 26th
June 17, 2008 16:05 ET
|
Savient Pharmaceuticals, Inc.
EAST BRUNSWICK, N.J., June 17, 2008 (PRIME NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Christopher Clement, President and Chief Executive Officer of Savient...
Christopher G. Clement, President and CEO of Savient Pharmaceuticals, Named Ernst & Young Entrepreneur of The Year 2008 Award Finalist in New Jersey
June 09, 2008 13:41 ET
|
Savient Pharmaceuticals, Inc.
EAST BRUNSWICK, N.J., June 9, 2008 (PRIME NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that President and CEO Christopher G. Clement is a finalist for The New Jersey Ernst...
Savient Pharmaceuticals to Present At Citi Investment Research Global Healthcare Conference On May 22nd
May 13, 2008 16:05 ET
|
Savient Pharmaceuticals, Inc.
EAST BRUNSWICK, N.J., May 13, 2008 (PRIME NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Paul Hamelin, Senior Vice President, Commercial Operations of Savient...
Savient Pharmaceuticals to Hold First Quarter 2008 Financial Results Conference Call On Thursday, May 8, 2008
April 16, 2008 16:15 ET
|
Savient Pharmaceuticals, Inc.
EAST BRUNSWICK, N.J., April 16, 2008 (PRIME NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) announced today that the company will release financial results for the first quarter 2008...